LFG
CGEM icon

Larson Financial Group’s Cullinan Oncology CGEM Stock Holding History

Larson Financial Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.08K Sell
279
-75
-21% -$1.11K ﹤0.01% 2768
2026
Q1 		$5.03K Buy
354
+314
+785% +$4.04K ﹤0.01% 2608
2025
Q4 		$414 Buy
+40
New +$361 ﹤0.01% 3159
2025
Q3 		– Sell
-56
Closed -$422 – 3476
2025
Q2 		$422 Sell
56
-520
-90% -$4.18K ﹤0.01% 2906
2025
Q1 		$4.36K Buy
+576
New +$5.53K ﹤0.01% 1920

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Larson Financial Group's CGEM Position: Q2 2026 in Review

Larson Financial Group reduced its Cullinan Oncology (CGEM) stake by 21% in Q2 2026, selling an estimated $1.11K and leaving 279 shares worth $5.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2768.

Larson Financial Group first reported a position in CGEM in Q1 2025 and has held it in 5 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Larson Financial Group held 279 shares of Cullinan Oncology worth $5.08K as of Q2 2026.
  • Larson Financial Group sold 75 Cullinan Oncology shares in Q2 2026, an estimated $1.11K.
  • Cullinan Oncology made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2768 holding.
  • Larson Financial Group first reported a position in Cullinan Oncology in Q1 2025 and has held it in 5 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.